These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 10829551)

  • 1. Statistical optimization of transdermal drug delivery system of terbutaline sulfate by factorial analysis.
    Manna A; Ghosh I; Sen N; Thakur RS; Ghosh LK; Gupta BK
    Boll Chim Farm; 2000; 139(1):34-40. PubMed ID: 10829551
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioequivalence of marketed transdermal delivery systems for tulobuterol.
    Tojo K; Hikima T
    Biol Pharm Bull; 2007 Aug; 30(8):1576-9. PubMed ID: 17666825
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Preparation and characterization of metoprolol tartrate containing matrix type transdermal drug delivery system.
    Malipeddi VR; Awasthi R; Ghisleni DD; de Souza Braga M; Kikuchi IS; de Jesus Andreoli Pinto T; Dua K
    Drug Deliv Transl Res; 2017 Feb; 7(1):66-76. PubMed ID: 27677866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effect of pH and organic ester penetration enhancers on skin permeation kinetics of terbutaline sulfate from pseudolatex-type transdermal delivery systems through mouse and human cadaver skins.
    Panigrahi L; Pattnaik S; Ghosal SK
    AAPS PharmSciTech; 2005 Sep; 6(2):E167-73. PubMed ID: 16353974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sumatriptan succinate transdermal delivery systems for the treatment of migraine.
    Balaguer-Fernández C; Femenía-Font A; Del Rio-Sancho S; Merino V; López-Castellano A
    J Pharm Sci; 2008 Jun; 97(6):2102-9. PubMed ID: 17854062
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Terbutaline transdermal delivery: preformulation studies and limitations of in-vitro predictive parameters.
    Tenjarla S; Puranajoti P; Kasina R; Mandal T
    J Pharm Pharmacol; 1996 Nov; 48(11):1138-42. PubMed ID: 8961161
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Double-layer weekly sustained release transdermal patch containing gestodene and ethinylestradiol.
    Gao Y; Liang J; Liu J; Xiao Y
    Int J Pharm; 2009 Jul; 377(1-2):128-34. PubMed ID: 19463930
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and in-vitro evaluation of transdermal matrix films of metoprolol tartrate.
    Bhatt DC; Dhake AS; Khar RK; Mishra DN
    Yakugaku Zasshi; 2008 Sep; 128(9):1325-31. PubMed ID: 18758147
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of monolithic matrix patch system containing tulobuterol.
    Rhee YS; Kwon SY; Park CW; Choi NY; Byun WJ; Chi SC; Park ES
    Arch Pharm Res; 2008 Aug; 31(8):1029-34. PubMed ID: 18787793
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of binder additives on terbutaline hydrogels of alpha-PVA/NaCl/H(2)O system in drug delivery: I. Effect of gelatin and soluble starch.
    Shaheen SM; Takezoe K; Yamaura K
    Biomed Mater Eng; 2004; 14(4):371-82. PubMed ID: 15472386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Physical and chemical permeation enhancers in transdermal delivery of terbutaline sulphate.
    Murthy SN; Hiremath SR
    AAPS PharmSciTech; 2001 Feb; 2(1):E-TN1. PubMed ID: 14727885
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formulation and in vitro evaluation of polymeric films of diltiazem hydrochloride and indomethacin for transdermal administration.
    Rao PR; Diwan PV
    Drug Dev Ind Pharm; 1998 Apr; 24(4):327-36. PubMed ID: 9876592
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Transdermal delivery of isosorbide 5-mononitrate from a new membrane reservoir and matrix-type patches.
    Arra GS; Arutla S; Krishna DR
    Drug Dev Ind Pharm; 1998 May; 24(5):489-92. PubMed ID: 9876613
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effect of penetration enhancers on the release and skin permeation of bupranolol from reservoir-type transdermal delivery systems.
    Babu RJ; Pandit JK
    Int J Pharm; 2005 Jan; 288(2):325-34. PubMed ID: 15620873
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Detection of tulobuterol crystal in transdermal patches using terahertz pulsed spectroscopy and imaging.
    Sakamoto T; Portieri A; Taday PF; Takada Y; Sasakura D; Aida K; Matsubara T; Miura T; Terahara T; Arnone DD; Kawanishi T; Hiyama Y
    Pharmazie; 2009 Jun; 64(6):361-5. PubMed ID: 19618670
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transdermal therapeutic system of isradipine: effect of hydrophilic and hydrophobic matrix on in vitro and ex vivo characteristics.
    Tirunagari M; Jangala VR; Khagga M; Gannu R
    Arch Pharm Res; 2010 Jul; 33(7):1025-33. PubMed ID: 20661712
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Enhanced transdermal controlled delivery of glimepiride from the ethylene-vinyl acetate matrix.
    Cho CW; Choi JS; Yang KH; Shin SC
    Drug Deliv; 2009 Aug; 16(6):320-30. PubMed ID: 19606946
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of carboxymethyl guar films for the formulation of transdermal therapeutic systems.
    Narasimha Murthy S; Hiremath SR; Paranjothy KL
    Int J Pharm; 2004 Mar; 272(1-2):11-8. PubMed ID: 15019064
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Single-layer transdermal film containing lidocaine: modulation of drug release.
    Padula C; Nicoli S; Colombo P; Santi P
    Eur J Pharm Biopharm; 2007 Jun; 66(3):422-8. PubMed ID: 17196804
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fast-dissolving sublingual films of terbutaline sulfate: formulation and in vitro/in vivo evaluation.
    Sayed S; Ibrahim HK; Mohamed MI; El-Milligi MF
    Mol Pharm; 2013 Aug; 10(8):2942-7. PubMed ID: 23883311
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.